TY - JOUR
TI - Favorable Outcome in Infants Hospitalized With COVID-19: Single Center Experience from Athens, Greece
AU - Dimopoulou, D.
AU - Liaska, M.
AU - Eleftheriou, I.
AU - Kourkouni, E.
AU - Tsolia, M.
AU - Spyridis, N.
JO - Indian Pediatrics
PY - 2022
VL - 59
TODO - 9
SP - 722-723
PB - Springer-Verlag
SN - 0019-6061, 0974-7559
TODO - 10.1007/s13312-022-2604-4
TODO - antiinfective agent;  C reactive protein;  corticosteroid;  remdesivir, Article;  campylobacteriosis;  clinical feature;  clinical outcome;  contact examination;  coronavirus disease 2019;  cycle threshold value;  disease severity;  female;  gastroenteritis;  Greece;  hospitalization;  human;  infant;  leukocyte count;  major clinical study;  male;  medical record review;  noninvasive ventilation;  oxygen therapy;  respiratory distress;  reverse transcription polymerase chain reaction;  treatment duration;  treatment outcome;  urinary tract infection;  virus load;  epidemiology;  retrospective study;  severity of illness index, COVID-19;  Greece;  Hospitalization;  Humans;  Infant;  Retrospective Studies;  Severity of Illness Index
TODO - This study aims to describe the clinical characteristics and outcome of 92 infants (aged <12 months) with community-acquired coronavirus disease 2019 (COVID-19) between March, 2020 and June, 2021 at a single center in Athens. Infants with COVID-19 developed mild disease (89, 96.7%), and were infected mostly by their household contacts (74, 80.4%). Disease complications were rare, indicating that hospitalization is the result of low threshold for admission rather than disease severity. © 2022, Indian Academy of Pediatrics.
ER -